These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8277498)

  • 1. CC-1065 functional analogues possessing different electron-withdrawing substituents and leaving groups: synthesis, kinetics, and sequence specificity of reaction with DNA and biological evaluation.
    Wang Y; Gupta R; Huang L; Lown JW
    J Med Chem; 1993 Dec; 36(26):4172-82. PubMed ID: 8277498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
    Boger DL; Johnson DS; Yun W; Tarby CM
    Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunit.
    Boger DL; Zarrinmayeh H; Munk SA; Kitos PA; Suntornwat O
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1431-5. PubMed ID: 1847523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
    Lee CS; Sun D; Kizu R; Hurley LH
    Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, cytotoxic properties and preliminary DNA sequencing evaluation of CPI--N-methylpyrrole hybrids. Enhancing effect of a trans double bond linker and role of the terminal amide functionality on cytotoxic potency.
    Wang Y; Gupta R; Huang L; Luo W; Lown JW
    Anticancer Drug Des; 1996 Jan; 11(1):15-34. PubMed ID: 8639246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
    Boger DL; Stauffer F; Hedrick MP
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
    Boger DL; Hughes TV; Hedrick MP
    J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of the covalent reaction of CC-1065 and analogues with DNA.
    Warpehoski MA; Harper DE; Mitchell MA; Monroe TJ
    Biochemistry; 1992 Mar; 31(9):2502-8. PubMed ID: 1547233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
    Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
    J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and DNA alkylation rates of the simplest functional analogues of CC-1065, para-hydroxy and para-amino phenethyl bromides.
    Shalders RL; Blanch G; Brown CL; Young DJ; Prakash AS
    Chem Biol Interact; 1999 Jan; 117(1):83-94. PubMed ID: 10190546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of interaction of CC-1065 (NSC 298223) with DNA.
    Swenson DH; Li LH; Hurley LH; Rokem JS; Petzold GL; Dayton BD; Wallace TL; Lin AH; Krueger WC
    Cancer Res; 1982 Jul; 42(7):2821-8. PubMed ID: 7083173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA.
    Hurley LH; Sun D
    J Mol Recognit; 1994 Jun; 7(2):123-32. PubMed ID: 7826672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions.
    Boger DL; Yun W; Han N; Johnson DS
    Bioorg Med Chem; 1995 Jun; 3(6):611-21. PubMed ID: 7582940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA sequence recognition by the antitumor antibiotic CC-1065 and analogs of CC-1065.
    Krueger WC; Hatzenbuhler NT; Prairie MD; Shea MH
    Chem Biol Interact; 1991; 79(3):265-86. PubMed ID: 1913973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065.
    Warpehoski MA; Gebhard I; Kelly RC; Krueger WC; Li LH; McGovren JP; Prairie MD; Wicnienski N; Wierenga W
    J Med Chem; 1988 Mar; 31(3):590-603. PubMed ID: 3346875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA.
    Sun D; Hurley LH
    J Med Chem; 1992 May; 35(10):1773-82. PubMed ID: 1588557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for sequence-specific DNA alkylation by CC-1065.
    Hurley LH; Lee CS; McGovren JP; Warpehoski MA; Mitchell MA; Kelly RC; Aristoff PA
    Biochemistry; 1988 May; 27(10):3886-92. PubMed ID: 3408734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T4 DNA ligase activity by (+)-CC-1065: demonstration of the importance of the stiffening and winding effects of (+)-CC-1065 on DNA.
    Sun D; Hurley LH
    Anticancer Drug Des; 1992 Feb; 7(1):15-36. PubMed ID: 1543525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.